Matrix-assisted autologous chondrocyte implantation into a 14cm(2) cartilage defect, caused by steroid-induced osteonecrosis.

Modern chemotherapy protocols have improved the prognosis for acute lymphoblastic leukaemia (ALL), one of the most common paediatric malignancies, but their high-dose corticosteroids lead to osteonecrosis in up to 9% of ALL patients. A 13.5-year-old female patient developed massive osteonecrosis of the right knee after successful ALL treatment. She presented at the age of 17.5 years as a candidate for knee arthroplasty after conservative treatment had failed. Magnetic Resonance Imaging (MRI) revealed severe osteonecrosis, with the cartilage layer of the medial femoral condyle completely detached from the bone. We preferred to attempt a two-step biological reconstruction in this young patient, with arthroscopy of the right knee joint and removal of the dissected cartilage layer of the medial condyle. Matrix-assisted autologous chondrocyte implantation (MACI) was performed with harvested chondrocytes after imaging had indicated vital bone remodelling. Rehabilitation was according to MACI guidelines and after 5.5 years, the patient shows continuous clinical improvement and is satisfied with the result. The Lysholm score improved from 45 to 99 and Tegner's activity score from 1 to 4. MRI follow-up showed a solid cartilage layer covering the medial condyle as a result of bone and chondral regeneration. Even if this approach had failed, bone remodelling would have still provided better conditions for knee arthroplasty.

[1]  G D Smith,et al.  A clinical review of cartilage repair techniques. , 2005, The Journal of bone and joint surgery. British volume.

[2]  Peter Behrens,et al.  Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)--5-year follow-up. , 2006, The Knee.

[3]  Maurilio Marcacci,et al.  Articular Cartilage Engineering with Hyalograft® C: 3-Year Clinical Results , 2005, Clinical orthopaedics and related research.

[4]  R. Gelber,et al.  Bony morbidity in children treated for acute lymphoblastic leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  T. Gioe,et al.  Knee Arthroplasty in the Young Patient: Survival in a Community Registry , 2007, Clinical orthopaedics and related research.

[6]  D. Reinhardt,et al.  Minimising the Long-Term Adverse Effects of Childhood Leukaemia Therapy , 2002, Drug safety.

[7]  S. Nehrer,et al.  Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. , 2006, European journal of radiology.

[8]  M. Brittberg,et al.  Treatment of Osteochondritis Dissecans of the Knee with Autologous Chondrocyte Transplantation: Results at Two to Ten Years , 2003, The Journal of bone and joint surgery. American volume.

[9]  J. Lysholm,et al.  Rating systems in the evaluation of knee ligament injuries. , 1985, Clinical orthopaedics and related research.

[10]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[11]  H. Sather,et al.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Schrappe,et al.  Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction , 2009, Leukemia.